Mercado Global de Biomateriais – Tendências e Previsão da Indústria para 2031

Análise e dimensão do mercado de biomateriais

No domínio da administração de fármacos, os biomateriais servem de espinha dorsal para sistemas inovadores, como as nanopartículas , as microesferas e os hidrogéis. Estas plataformas encapsulam os agentes terapêuticos, protegendo-os da degradação e permitindo a entrega precisa em locais-alvo do organismo. As nanopartículas, normalmente à escala nanométrica, oferecem maior absorção celular e tempos de circulação prolongados. As microesferas proporcionam uma cinética de libertação controlada, garantindo níveis terapêuticos sustentados durante longos períodos. Os hidrogéis, com as suas propriedades ajustáveis, oferecem um controlo espacial e temporal sobre a libertação do fármaco, atendendo a condições fisiológicas específicas.

O tamanho do mercado global de biomateriais foi avaliado em 176,73 mil milhões de dólares em 2023 e deverá atingir os 503,42 mil milhões de dólares até 2031, com um CAGR de 13,98% durante o período de previsão de 2024 a 2031. Para além dos insights sobre cenários de mercado, tais como mercado valor, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research também incluem análises especializadas aprofundadas, epidemiologia de pacientes, análise de pipeline, análise de preços e estrutura regulatória.

Âmbito do relatório e segmentação de mercado       

Definição de mercado

Os biomateriais são substâncias concebidas para interagir com sistemas biológicos para fins médicos, desde implantes e próteses a sistemas de administração de fármacos. São concebidos para serem compatíveis com os tecidos vivos, promovendo a cicatrização e a regeneração, ao mesmo tempo que possuem propriedades mecânicas, químicas e biológicas específicas. Os biomateriais desempenham um papel crucial em diversas aplicações médicas, facilitando os avanços na área da saúde e melhorando os resultados dos pacientes.

Dinâmica do mercado de transplante capilar

Motoristas                                                                                          

• Crescentes avanços tecnológicos

Os avanços na ciência dos materiais, na nanotecnologia e na biotecnologia melhoram continuamente as propriedades e funcionalidades dos biomateriais, desbloqueando novas aplicações e melhorando as existentes. Estes avanços permitem o desenvolvimento de biomateriais com propriedades personalizadas, como a biocompatibilidade, a resistência mecânica e a degradação controlada, atendendo às diversas necessidades das indústrias médica, farmacêutica e outras. Os avanços nos processos de fabrico, como a fabricação aditiva e a biofabricação, permitem a produção de estruturas complexas de biomateriais com um controlo preciso à micro e nanoescala, impulsionando o mercado.

• Aumento da população idosa

O crescente envelhecimento da população está mais propenso a problemas de saúde relacionados com a idade, como osteoartrite, doenças cardiovasculares e problemas dentários, necessitando da utilização de biomateriais em implantes médicos, próteses e soluções de engenharia de tecidos. Os biomateriais desempenham um papel crucial na restauração da função e da qualidade de vida dos idosos, fornecendo substitutos duráveis ​​e biocompatíveis para tecidos e órgãos degenerados. A procura de biomateriais é amplificada pelo desejo de estilos de vida activos e independentes entre os idosos, impulsionando a inovação na ciência dos materiais e na engenharia biomédica para satisfazer as necessidades únicas deste grupo demográfico.

Oportunidades

• Aumentando as políticas governamentais de apoio

Políticas como as bolsas de investigação, os incentivos fiscais e os quadros regulamentares destinados a promover a inovação nos cuidados de saúde e na biotecnologia estimulam o investimento na investigação e desenvolvimento de biomateriais. Além disso, as iniciativas governamentais centradas no desenvolvimento de infra-estruturas de saúde e em programas de saúde pública criam procura por biomateriais avançados utilizados em dispositivos médicos , implantes e medicina regenerativa . As políticas de apoio aceleram a tradução da investigação em biomateriais em produtos e terapias tangíveis, promovendo a colaboração entre o meio académico, a indústria e os organismos reguladores que, em última análise, impulsionam a expansão do mercado e a melhoria dos resultados dos doentes.

• Aumento da procura por procedimentos minimamente invasivos

Patients seek less invasive treatment options through which there's a growing need for biomaterials that enable the development of advanced medical devices and surgical techniques. Biomaterials play a pivotal role in these procedures by providing materials for implants, instruments, and surgical tools that are compatible with the body and promote healing. Moreover, biomaterials facilitate the creation of specialized coatings and drug delivery systems used in minimally invasive interventions, enhancing their efficacy and safety. This trend towards minimally invasive procedures drives innovation in biomaterials, spurring research and development efforts to meet the evolving needs of patients and healthcare providers.

Restraints/Challenges

• High Development Costs

The research and development process for biomaterials involves substantial investment in specialized equipment, materials, and skilled personnel. In addition, conducting preclinical and clinical trials to ensure safety and efficacy further adds to the expense. These high costs can deter smaller companies and startups from entering the market, limiting competition and innovation. Moreover, the lengthy development timeline coupled with uncertain regulatory pathways can prolong the time to market, increasing overall expenses and hindering profitability.

• Growing Competition from Alternative Therapies

Traditional treatment modalities such as pharmaceuticals, surgeries, and non-invasive procedures offer established alternatives to biomaterial-based interventions. Patients or healthcare providers may prefer these alternatives due to factors such as familiarity, perceived efficacy, or cost-effectiveness. Biomaterials face stiff competition in the healthcare landscape, requiring continuous innovation and differentiation to maintain market relevance and capture market share.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In October 2023, Evonik launched VESTAKEEP iC4612 3DF and iC4620 3DF, pioneering carbon-fiber-reinforced PEEK filaments for 3D-printed medical implants. These filaments offer a unique combination of strength, ductility, and adaptability, marking a significant leap in personalized medical treatments and underlining Evonik's dedication to innovation in patient care
• In April 2023, Novo Nordisk forged a strategic collaboration with Aspect Biosystems to develop bioprinted tissue therapeutics targeting obesity and diabetes. This collaboration leverages Aspect Biosystems' expertise in bioprinting biomaterials, aligning with Novo Nordisk's commitment to advancing cutting-edge treatments for metabolic disorders
• In March 2023, Invibio Biomaterial Solutions launched Peek-Optima Am filament, a polyetheretherketone polymer-based material designed for the 3D printing of medical devices. This launch expands Invibio's portfolio of innovative biomaterials, offering enhanced manufacturing capabilities for medical applications and reinforcing its position as a leader in the biomaterials industry
• In January 2023, Zimmer Biomet Holdings, Inc. announced its acquisition plans for Embody, Inc., with an initial investment of USD 155 million, potentially increasing to USD 275 million based on future milestones. This strategic move aims to bolster Zimmer Biomet's sports medicine portfolio, particularly focusing on advanced soft tissue healing solutions, reflecting the company's commitment to expanding its product offerings through strategic acquisitions

Biomaterials Market Scope

The market is segmented on the basis of type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Metallic Biomaterials
  • Stainless Steel
  • Titanium and Titanium Alloys
  • Cobalt-Chrome Alloys
  • Gold
  • Silver
  • Magnesium
• Polymeric Biomaterials
  • Polymethylmethacrylate
  • Polyethylene
  • Polyester
  • Polyvinylchloride
  • Silicone Rubber
  • Nylon
  • Polyetheretherketone
  • Other Polymeric Biomaterials
• Ceramics
  • Calcium Phosphate
  • Zirconia
  • Aluminum Oxide
  • Calcium Sulfate
  • Carbon
  • Glass
• Natural Biomaterials
  • Hyaluronic Acid
  • Collagen
  • Gelatin
  • Fibrin
  • Cellulose
  • Chitin
  • Alginates
  • Silk

Application

• Cardiovascular
  • Catheters
  • Stents
  • Implantable Cardiac Defibrillators
  • Pacemakers
  • Sensors
  • Heart Valves
  • Vascular Grafts
  • Guidewires
  • Others
• Orthopaedic
  • Joint Replacement
  • Knee Replacement
  • Hip Replacement
  • Shoulder Replacement
  • Others
• Ophthalmology
  • Contact Lenses
  • Intraocular Lenses
  • Functional Replacement of Ocular Tissues
  • Synthetic Corneas
  • Others
• Dental
  • Dental Implants
  • Dental Bone Grafts and Substitutes
  • Dental Membranes
  • Tissue Regeneration
• Plastic Surgery
  • Soft-Tissue Fillers
  • Craniofacial Surgery
• Wound Healing
  • Wound Closure Devices
  • Sutures
  • Staples
  • Surgical Hemostats
  • Internal Tissue Sealants
  • Adhesion Barriers
  • Hernia Meshes
• Tissue Engineering
  • Scaffolds for Regenerative Medicine
  • Nanomaterials for Biosensing
  • Tailoring of Inorganic Nanoparticles
• Neurological/Central Nervous System Applications
  • Shunting Systems
  • Cortical Neural Prosthetics
  • Hydrogel Scaffolds for CNS Repair
  • Neural Stem Cell Encapsulation
• Other Applications
  • Drug Delivery Systems
  • Gastrointestinal Applications
  • Bariatric Surgery
  • Urinary Applications

 Biomaterials Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, type, and application, as referenced above.

The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.   

North America is expected to dominate the market is fueled by a combination of favorable government policies supporting research and development initiatives and stringent regulatory frameworks that encourage innovation. Additionally, the region benefits from the presence of numerous major market players, fostering a robust ecosystem for collaboration and investment. This conducive environment has propelled North America to the forefront of biomaterials innovation, driving advancements in medical devices, tissue engineering, and regenerative medicine.

Asia-Pacific is expected to have significant growth due to strategic initiatives undertaken by local stakeholders to bolster their market presence both domestically and internationally. These initiatives encompass various measures such as investment in infrastructure, technological advancements, and fostering partnerships to enhance competitiveness. As a result, the region is expected to experience robust economic expansion, driving growth in diverse sectors and solidifying its position as a key player in the market landscape.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Biomaterials Market Analysis

O cenário competitivo do mercado fornece detalhes dos concorrentes. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produtos, largura e amplitude do produto, domínio da aplicação. Os dados acima fornecidos estão apenas relacionados com o foco das empresas em relação ao mercado.

Alguns dos principais players que operam no mercado são:

• Johnson & Johnson. (NÓS)
• Stryker. (NÓS)
• (EUA)
• Zimmer Biomet (EUA)
• Corbionollagen Matrix, Inc.
• CRS Participações, Lda. (NÓS)
• Biomateriais Avançados de Berkeley (EUA)
• (Canadá)
• Medtronic plc (Irlanda)
• BASF SE (Alemanha)
• Evonik Industries AG (Alemanha)
• (Reino Unido)

SKU-59542